Published in Occup Environ Med on November 01, 1996
Risk factors for acute leukemia in children: a review. Environ Health Perspect (2007) 2.57
A case-control study to investigate the risk of leukaemia associated with exposure to benzene in petroleum marketing and distribution workers in the United Kingdom. Occup Environ Med (1997) 1.91
Reporting of occupational and environmental research: use and misuse of statistical and epidemiological methods. Occup Environ Med (2000) 1.84
Meta-analysis of benzene exposure and non-Hodgkin lymphoma: biases could mask an important association. Occup Environ Med (2008) 1.82
Occupational benzene exposure and the risk of lymphoma subtypes: a meta-analysis of cohort studies incorporating three study quality dimensions. Environ Health Perspect (2010) 1.40
Exposure to benzene at work and the risk of leukemia: a systematic review and meta-analysis. Environ Health (2010) 1.39
Myelodysplastic syndrome and benzene exposure among petroleum workers: an international pooled analysis. J Natl Cancer Inst (2012) 1.31
Lymphohaematopoeitic cancer mortality among workers with benzene exposure. Occup Environ Med (2003) 1.20
Mortality and cancer morbidity in a cohort of Canadian petroleum workers. Occup Environ Med (2003) 0.94
Flexible meta-regression to assess the shape of the benzene-leukemia exposure-response curve. Environ Health Perspect (2009) 0.92
Updated mortality among diverse operating segments of a petroleum company. Occup Environ Med (2000) 0.91
Acute myeloid and chronic lymphoid leukaemias and exposure to low-level benzene among petroleum workers. Br J Cancer (2013) 0.85
The use of biomonitoring data in exposure and human health risk assessment: benzene case study. Crit Rev Toxicol (2013) 0.83
Nested case-control study of leukaemia, multiple myeloma, and kidney cancer in a cohort of petroleum workers exposed to gasoline. Occup Environ Med (1999) 0.82
A review of the data quality and comparability of case-control studies of low-level exposure to benzene in the petroleum industry. Int Arch Occup Environ Health (2009) 0.78
Occupational Exposure to Benzene and Non-Hodgkin Lymphoma in a Population-Based Cohort: The Shanghai Women's Health Study. Environ Health Perspect (2015) 0.77
Comparison of the diagnosis of leukaemia from death certificates, cancer registration and histological reports - implications for occupational case-control studies. Br J Cancer (1997) 0.75
Benzene exposure and risk of lymphohaematopoietic cancers in 25 000 offshore oil industry workers. Br J Cancer (2015) 0.75
Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst (1959) 94.48
Benzene and leukemia. An epidemiologic risk assessment. N Engl J Med (1987) 5.06
Leukaemia in benzene workers. Lancet (1977) 3.55
Leukemia in shoe-workers exposed chronically to benzene. Blood (1974) 2.52
BENZENE AND LEUKEMIA. N Engl J Med (1964) 2.44
Benzene and leukemia. A review of the literature and a risk assessment. Am J Epidemiol (1988) 2.36
Defining exposure in case-control studies: a new approach. Am J Epidemiol (1991) 2.35
Mortality among chemical workers exposed to benzene and other agents. Environ Res (1983) 1.94
Latency analysis in occupational epidemiology. Arch Environ Health (1990) 1.77
Smoking and leukemia: evaluation of a causal hypothesis. Am J Epidemiol (1993) 1.69
History of cigarette smoking and risk of leukemia and myeloma: results from the Adventist health study. J Natl Cancer Inst (1990) 1.60
Leukemia associated with benzene exposure. Ann N Y Acad Sci (1976) 1.56
An update of mortality among chemical workers exposed to benzene. Br J Ind Med (1986) 1.56
The 4th nation-wide study of adult T-cell leukemia/lymphoma (ATL) in Japan: estimates of risk of ATL and its geographical and clinical features. The T- and B-cell Malignancy Study Group. Int J Cancer (1990) 1.51
Further follow up of mortality in a United Kingdom oil distribution centre cohort. Br J Ind Med (1993) 1.42
An industry wide mortality study of chemical workers occupationally exposed to benzene. II. Dose response analyses. Br J Ind Med (1987) 1.39
Health effects of gasoline exposure. II. Mortality patterns of distribution workers in the United States. Environ Health Perspect (1993) 1.39
A retrospective mortality study among Canadian petroleum marketing and distribution workers. Environ Health Perspect (1993) 1.39
Smoking and risk of non-Hodgkin's lymphoma and multiple myeloma. Cancer Causes Control (1992) 1.35
Risk of benzene-induced leukemia: a sensitivity analysis of the pliofilm cohort with additional follow-up and new exposure estimates. J Toxicol Environ Health (1994) 1.33
Risk assessment of leukaemia and occupational exposure to benzene. Br J Ind Med (1989) 1.30
Leukemia risk associated with benzene exposure in the pliofilm cohort: I. Mortality update and exposure distribution. Risk Anal (1994) 1.28
Review and update of leukemia risk potentially associated with occupational exposure to benzene. Environ Health Perspect (1989) 1.20
Leukaemia and smoking habits among United States veterans. BMJ (1988) 1.16
A retrospective mortality study within operating segments of a petroleum company. Am J Ind Med (1992) 1.10
The epidemiology of non-Hodgkin's lymphoma in the north-east of Italy: a hospital-based case-control study. Leuk Res (1989) 1.08
Some occupational exposures as risk factors for malignant lymphomas. Cancer (1993) 1.07
Multiple myeloma and family history of cancer. A case-control study. Cancer (1985) 1.01
A prospective study in the Australian petroleum industry. I. Mortality. Br J Ind Med (1991) 1.00
Benzene as a leukemogenic and carcinogenic agent. Am J Ind Med (1985) 0.99
Is cigarette smoking a risk factor for non-Hodgkin's lymphoma or multiple myeloma? Results from the Lutheran Brotherhood Cohort Study. Leuk Res (1992) 0.98
Retrospective benzene and total hydrocarbon exposure assessment for a petroleum marketing and distribution worker epidemiology study. Am Ind Hyg Assoc J (1996) 0.96
Leukemia risk associated with benzene exposure in the pliofilm cohort. II. Risk estimates. Risk Anal (1994) 0.95
Cigarette smoking and leukemia: results from the Lutheran Brotherhood Cohort Study. Cancer Causes Control (1991) 0.82
Smoking and multiple myeloma. Cancer Causes Control (1992) 0.78
Modification of the Minitek Miniaturized Differentiation System for characterization of anaerobic bacteria. J Clin Microbiol (1976) 6.00
Micromethod system for identification of anaerobic bacteria. Appl Microbiol (1973) 4.18
Lipid-membrane interactions and the pathogenesis of ischemic damage in the myocardium. Circ Res (1981) 2.24
Contractile proteins of the heart. Physiol Rev (1970) 2.10
Editorial: the early "pump" failure of the ischemic heart. Am J Med (1969) 1.92
The stimulation of calcium transport in cardiac sarcoplasmic reticulum by adenosine 3':5'-monophosphate-dependent protein kinase. J Biol Chem (1974) 1.81
Phosphorylation of the sarcoplasmic reticulum and sarcolemma. Annu Rev Physiol (1982) 1.60
Phosphorylation of a 22,000-dalton component of the cardiac sarcoplasmic reticulum by adenosine 3':5'-monophosphate-dependent protein kinase. J Biol Chem (1975) 1.58
Physiological characterization of nutritionally variant streptococci. J Clin Microbiol (1979) 1.57
Adenosine 3':5'-monophosphate-dependent protein kinase-catalyzed phosphorylation reaction and its relationship to calcium transport in cardiac sarcoplasmic reticulum. J Biol Chem (1974) 1.52
Norleucine-tyrosine broth for rapid identification of Clostridium difficile by gas-liquid chromatography. J Clin Microbiol (1983) 1.47
A retrospective mortality study among Canadian petroleum marketing and distribution workers. Environ Health Perspect (1993) 1.39
Estimation of epidermal carcinogenic potency. Fundam Appl Toxicol (1990) 1.38
Role of the contractile proteins and sarcoplasmic reticulum in the response of the heart to catecholamines: an historical review. Adv Cyclic Nucleotide Res (1979) 1.32
Low stress reactivity and neuroendocrine factors in the BTBR T+tf/J mouse model of autism. Neuroscience (2010) 1.30
Cyclic adenosine 3',5'-monophosphate-dependent protein kinase stimulation of calcium uptake by canine cardiac microsomes. J Mol Cell Cardiol (1972) 1.26
Characterization of dog cardiac microsomes. Use of zonal centrifugation to fractionate fragmented sarcoplasmic reticulum, (Na+ + K+)--activated ATPase and mitochondrial fragments. Biochim Biophys Acta (1970) 1.22
Rapid ventricular filling in left ventricular hypertrophy: II. Pathologic hypertrophy. J Am Coll Cardiol (1985) 1.19
Calcium transport ATPase of canine cardiac sarcoplasmic reticulum. A comparison with that of rabbit fast skeletal muscle sarcoplasmic reticulum. J Biol Chem (1976) 1.18
Quantitative aspects of dog cardiac microsomal calcium binding and calcium uptake. Circ Res (1967) 1.15
Control of myocardial contraction: the sensitivity of cardiac actomyosin to calcium ion. Science (1966) 1.12
Mechanism of early "pump" failure of the ischemic heart: possible role of adenosine triphosphate depletion and inorganic phosphate accumulation. Am J Cardiol (1977) 1.12
Control of calcium transport in the myocardium by the cyclic AMP-Protein kinase system. Adv Cyclic Nucleotide Res (1975) 1.11
Characteristics of participants and nonparticipants in worksite health promotion. Am J Health Promot (1997) 1.11
Binding of the calcium channel blocker nitrendipine to its receptor in purified sarcolemma from canine cardiac ventricle. J Mol Cell Cardiol (1983) 1.10
A retrospective mortality study within operating segments of a petroleum company. Am J Ind Med (1992) 1.10
Phospholamban: a regulatory protein of the cardiac sarcoplasmic reticulum. Recent Adv Stud Cardiac Struct Metab (1975) 1.08
Calcium-membrane interactions in the myocardium: effects of ouabain, epinephrine and 3',5'-cyclic adenosine monophosphate. Am J Cardiol (1973) 1.05
Mechanism by which cyclic adenosine 3':5'-monophosphate-dependent protein kinase stimulates calcium transport in cardiac sarcoplasmic reticulum. Circ Res (1979) 1.04
Comparisons of the interaction of propranolol and timolol with model and biological membrane systems. Mol Pharmacol (1983) 1.04
Clostridium difficile. Colonization and toxin production in a cohort of patients with malignant hematologic disorders. Arch Intern Med (1984) 1.03
The report of the American Heart Association task force on strategies to increase federal research funding. Circulation (1990) 1.03
Regulation of cardiac muscle contractility. J Gen Physiol (1967) 1.02
The "stone heart" and other challenges to the biochemist. Am J Cardiol (1977) 1.02
The descending limb of the Starling curve and the failing heart. Circulation (1965) 1.02
Retrospective estimation of exposure to benzene in a leukaemia case-control study of petroleum marketing and distribution workers in the United Kingdom. Occup Environ Med (1997) 1.00
An analysis of death ascertainment and follow-up through statistics Canada's Mortality Data Base system. Can J Public Health (1990) 1.00
Increased risk of urgent revascularization. J Thorac Cardiovasc Surg (1987) 0.99
Sodium and potassium sensitivity of calcium uptake and calcium binding by dog cardiac microsomes. Circ Res (1967) 0.98
Evaluation of Port-A-Cul transport system for protection of anaerobic bacteria. J Clin Microbiol (1978) 0.97
Comparison of high affinity binding of calcium channel blocking drugs to vascular smooth muscle and cardiac sarcolemmal membranes. Biochem Pharmacol (1984) 0.96
Retrospective benzene and total hydrocarbon exposure assessment for a petroleum marketing and distribution worker epidemiology study. Am Ind Hyg Assoc J (1996) 0.96
Cyclic adenosine monophosphate effects on the myocardium: a man who blows hot and cold with one breath. J Am Coll Cardiol (1983) 0.95
Calcium fluxes across the membrane of sarcoplasmic reticulum vesicles. J Biol Chem (1982) 0.94
Mortality and cancer morbidity in a cohort of Canadian petroleum workers. Occup Environ Med (2003) 0.94
The "stone heart": a challenge to the biochemist. Am J Cardiol (1972) 0.93
The relationship between low-level benzene exposure and leukemia in Canadian petroleum distribution workers. Environ Health Perspect (1996) 0.92
Cellular calcium and cardiac cell death. Am J Cardiol (1979) 0.92
Purification and properties of a tropomyosin-containing protein fraction that sensitizes reconstituted actomyosin to calcium-binding agents. J Biol Chem (1966) 0.92
Dependence of ionophore- and caffeine-induced calcium release from sarcoplasmic reticulum vesicles on external and internal calcium ion concentrations. J Biol Chem (1977) 0.92
Effects of ischemia on the contractile processes of heart muscle. Am J Cardiol (1973) 0.91
Updated mortality among diverse operating segments of a petroleum company. Occup Environ Med (2000) 0.91
Effects of azumolene on doxorubicin-induced Ca2+ release from skeletal and cardiac muscle sarcoplasmic reticulum. Biochim Biophys Acta (1991) 0.90
Biochemical "defect" in the hypertrophied and failing heart: deleterious or compensatory? Circulation (1973) 0.90
Effect of physical training on calcium transport by rat cardiac sarcoplasmic reticulum. Circ Res (1977) 0.89
Inotropic and lusitropic abnormalities in the genesis of heart failure. Eur Heart J (1983) 0.88
Congestive heart failure: role of altered myocardial cellular control. N Engl J Med (1975) 0.88
Rapid ventricular filling in left ventricular hypertrophy: I. Physiologic hypertrophy. J Am Coll Cardiol (1985) 0.88
Dependence of calcium permeability of sarcoplasmic reticulum vesicles on external and internal calcium ion concentrations. J Biol Chem (1977) 0.88
Two-generation reproduction study in rats given di-isononyl phthalate in the diet. Reprod Toxicol (2000) 0.87
Comparison of ambient PM risk with risks estimated from PM components of smoking and occupational exposures. J Air Waste Manag Assoc (2000) 0.87
Possible molecular basis for the pharmacokinetics and pharmacodynamics of three membrane-active drugs: propranolol, nimodipine and amiodarone. J Mol Cell Cardiol (1988) 0.87
The force-velocity curve. A biochemist's viewpoint, 1971. Cardiology (1972) 0.87
Potential deleterious effects of inotropic agents in the therapy of chronic heart failure. Circulation (1986) 0.87
The modification of unidirectional calcium fluxes by dibucaine in sarcoplasmic reticulum vesicles from rabbit fast skeletal muscle. Mol Pharmacol (1980) 0.86
Effects of ethanol on calcium binding and calcium uptake by cardiac microsomes. Biochem Pharmacol (1974) 0.86
A new inotropic drug: its promise and a caution. N Engl J Med (1978) 0.85
Clinical and electrocardiographic features of cardiac rupture following acute myocardial infarction. Am J Med (1971) 0.85
Doxorubicin-induced calcium release from cardiac sarcoplasmic reticulum vesicles. J Mol Cell Cardiol (1989) 0.85
Muscle damage produced by chronic alcohol consumption. Am J Pathol (1976) 0.85
Regulation of calcium transport in cardiac sarcoplasmic reticulum by cyclic AMP-dependent protein kinase. Recent Adv Stud Cardiac Struct Metab (1976) 0.85
Control of cardiac sarcolemmal adenylate cyclase and sodium, potassium-activated adenosinetriphosphatase activities. Circ Res (1975) 0.85
Membrane-derived lipids and the pathogenesis of ischemic myocardial damage. J Mol Cell Cardiol (1982) 0.85
Determination of leukemogenic benzene exposure concentrations: refined analyses of the Pliofilm cohort. Risk Anal (1996) 0.84
A nested case-control study of kidney cancer among refinery/petrochemical workers. Environ Health Perspect (1996) 0.83
Effects of fatty acids on Na/Ca exchange in cardiac sarcolemmal membranes. J Mol Cell Cardiol (1985) 0.83
Mortality experience of a young petrochemical industry cohort. 1979-1992 follow-up study of US-based employees. J Occup Environ Med (1997) 0.83
Control of calcium efflux from sarcoplasmic reticulum vesicles by external calcium. J Biol Chem (1977) 0.83
Selective dopamine-1 agonist therapy in severe hypertension: effects of intravenous fenoldopam. J Am Coll Cardiol (1988) 0.83
An evaluation of scheduled bright light and darkness on rotating shiftworkers: trial and limitations. Am J Ind Med (1995) 0.83
Predicting medical specialty choice: a model based on students' records. J Med Educ (1984) 0.83
The interaction of drugs with the sarcoplasmic reticulum. Annu Rev Pharmacol Toxicol (1982) 0.83
Ensuring comparability of benzene exposure estimates across three nested case-control studies in the petroleum industry in support of a pooled epidemiological analysis. Chem Biol Interact (2009) 0.83
Basic cellular mechanisms of action of the calcium-channel blockers. Am J Cardiol (1985) 0.82
Influence of parental and biological factors on the male birth fraction in the United States: an analysis of birth certificate data from 1964 through 1988. Fertil Steril (2000) 0.82
Reconstitution of an active calcium pump in sarcoplasmic reticulum. J Biol Chem (1976) 0.82
Pharmacology and mechanisms of action of calcium-channel blockers. J Clin Hypertens (1986) 0.82